128 related articles for article (PubMed ID: 35483400)
1. Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Trutnovsky G; Reich O; Joura EA; Holter M; Ciresa-König A; Widschwendter A; Schauer C; Bogner G; Jan Z; Boandl A; Kalteis MS; Regauer S; Tamussino K
Lancet; 2022 May; 399(10337):1790-1798. PubMed ID: 35483400
[TBL] [Abstract][Full Text] [Related]
2. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Lawrie TA; Nordin A; Chakrabarti M; Bryant A; Kaushik S; Pepas L
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011837. PubMed ID: 26728940
[TBL] [Abstract][Full Text] [Related]
3. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
Tristram A; Hurt CN; Madden T; Powell N; Man S; Hibbitts S; Dutton P; Jones S; Nordin AJ; Naik R; Fiander A; Griffiths G
Lancet Oncol; 2014 Nov; 15(12):1361-8. PubMed ID: 25304851
[TBL] [Abstract][Full Text] [Related]
4. Aesthetic Outcome and Psychosexual Distress After Treatment for Vulvar High-Grade Squamous Intraepithelial Lesions.
Trutnovsky G; Holter M; Gold D; Kopera D; Deban J; Misut D; Aust S; Tamussino K; Greimel E
J Low Genit Tract Dis; 2024 Jan; 28(1):48-53. PubMed ID: 37934148
[TBL] [Abstract][Full Text] [Related]
5. Management of Vulvar Cancer Precursors: A Survey of the International Society for the Study of Vulvovaginal Disease.
Green N; Adedipe T; Dmytryshyn J; Preti M; Selk A
J Low Genit Tract Dis; 2020 Oct; 24(4):387-391. PubMed ID: 32986387
[TBL] [Abstract][Full Text] [Related]
6. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.
Preti M; Joura E; Vieira-Baptista P; Van Beurden M; Bevilacqua F; Bleeker MCG; Bornstein J; Carcopino X; Chargari C; Cruickshank ME; Erzeneoglu BE; Gallio N; Heller D; Kesic V; Reich O; Stockdale CK; Temiz BE; Woelber L; Planchamp F; Zodzika J; Querleu D; Gultekin M
J Low Genit Tract Dis; 2022 Jul; 26(3):229-244. PubMed ID: 35763611
[TBL] [Abstract][Full Text] [Related]
7. Medical interventions for high-grade vulval intraepithelial neoplasia.
Pepas L; Kaushik S; Nordin A; Bryant A; Lawrie TA
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007924. PubMed ID: 26284429
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Polterauer S; Reich O; Widschwendter A; Hadjari L; Bogner G; Reinthaller A; Joura E; Trutnovsky G; Ciresa-Koenig A; Ganhoer-Schimboeck J; Boehm I; Berger R; Langthaler E; Aberle SW; Heinze G; Gleiss A; Grimm C
Gynecol Oncol; 2022 Apr; 165(1):23-29. PubMed ID: 35177279
[TBL] [Abstract][Full Text] [Related]
9. A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
Abdulrahman Z; de Miranda NFCC; Hellebrekers BWJ; de Vos van Steenwijk PJ; van Esch EMG; van der Burg SH; van Poelgeest MIE
Int J Cancer; 2020 Nov; 147(10):2914-2923. PubMed ID: 32574376
[TBL] [Abstract][Full Text] [Related]
10. Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
van Seters M; van Beurden M; ten Kate FJ; Beckmann I; Ewing PC; Eijkemans MJ; Kagie MJ; Meijer CJ; Aaronson NK; Kleinjan A; Heijmans-Antonissen C; Zijlstra FJ; Burger MP; Helmerhorst TJ
N Engl J Med; 2008 Apr; 358(14):1465-73. PubMed ID: 18385498
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
12. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer.
Xavier J; Figueiredo R; Vieira-Baptista P
J Low Genit Tract Dis; 2023 Apr; 27(2):125-130. PubMed ID: 36794761
[TBL] [Abstract][Full Text] [Related]
13. Vulvar High-Grade Squamous Intraepithelial Lesions Treated with Imiquimod: Can Persistence of Human Papillomavirus Predict Recurrence?
Fernández-Montolí ME; Heydari F; Lavecchia F; Pavón MÂ; Guerra E; Matias-Guiu X; Marti MD; Tous S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230731
[No Abstract] [Full Text] [Related]
14. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions.
Preti M; Joura E; Vieira-Baptista P; Van Beurden M; Bevilacqua F; Bleeker MCG; Bornstein J; Carcopino X; Chargari C; Cruickshank ME; Erzeneoglu BE; Gallio N; Heller D; Kesic V; Reich O; Stockdale CK; Esat Temiz B; Woelber L; Planchamp F; Zodzika J; Querleu D; Gultekin M
Int J Gynecol Cancer; 2022 Jul; 32(7):830-845. PubMed ID: 35728950
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for unrecognized invasive carcinoma in patients with vulvar high-grade squamous intraepithelial lesion at vulvoscopy-directed biopsy.
Preti M; Bucchi L; Ghiringhello B; Privitera S; Frau V; Corvetto E; Benedetto C; Micheletti L
J Gynecol Oncol; 2017 Jul; 28(4):e27. PubMed ID: 28541626
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
Hurt CN; Jones S; Madden TA; Fiander A; Nordin AJ; Naik R; Powell N; Carucci M; Tristram A
BJOG; 2018 Aug; 125(9):1171-1177. PubMed ID: 29336101
[TBL] [Abstract][Full Text] [Related]
17. Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.
van de Sande AJM; van Baars R; Koeneman MM; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Willemsen SP; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
BJOG; 2024 Mar; ():. PubMed ID: 38556619
[TBL] [Abstract][Full Text] [Related]
18. The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease.
van der Linden M; van Hees CL; van Beurden M; Bulten J; van Dorst EB; Esajas MD; Meeuwis KA; Boll D; van Poelgeest MI; de Hullu JA
Am J Obstet Gynecol; 2022 Aug; 227(2):250.e1-250.e8. PubMed ID: 35447145
[TBL] [Abstract][Full Text] [Related]
19. Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia.
Hurt CN; Nedjai B; Alvarez-Mendoza C; Powell N; Tristram A; Jones S
Cancer Biomark; 2022; 35(2):143-153. PubMed ID: 35912731
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination.
Abdulrahman Z; de Miranda N; van Esch EMG; de Vos van Steenwijk PJ; Nijman HW; J P Welters M; van Poelgeest MIE; van der Burg SH
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
